Heart protection by managing potassium levels during dialysis
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests whether closely managing potassium levels during hemodialysis can help protect the heart in patients with kidney failure who are on maintenance dialysis. It aims to reduce the risk of heart problems related to potassium swings.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been on maintenance hemodialysis for at least 3 months.
- Your potassium level before dialysis is between 5.0 and 8.0 mmol/L (a blood test will confirm this).
- You are able to make decisions and follow the study instructions.
- You do not have serious heart conditions (like congenital heart disease or a history of heart attack), severe infections, active cancer, or major mental disorders.
- You do not have severe constipation or intestinal blockage.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how high potassium levels (hyperkalemia) in people with chronic kidney disease may affect the heart. Doctors will use echocardiograms (heart ultrasounds) to check for changes.
This study tests whether relaxing the usual potassium restrictions in your diet is safe and helpful for people on hemodialysis. It may allow you to eat more foods you enjoy while keeping your potassium at a safe level.
This study tests if careful potassium management can help people with chronic kidney disease (CKD) safely take higher doses of blood pressure medicines called ACE inhibitors or ARBs, which are known to protect the kidneys. You may be eligible if you have moderate to advanced CKD and are already on a moderate dose of one of these medications.
This study looks at how common high potassium levels are in people with chronic kidney disease who are not on dialysis. It may help find who is at risk and how to prevent it.
This trial tests a medication (SZC) that helps lower high potassium levels, so you can keep taking important heart and kidney drugs (RAASi/MRA). It is for people with heart failure and chronic kidney disease who have high potassium.
This trial tests how safe and effective SZC is for children with high potassium levels (hyperkalaemia) over the short term, and possibly long term. It aims to help lower potassium safely and see whether it works well in different pediatric age groups.
Hear when a new Chronic Kidney Disease on Hemodialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.